{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T12:21:21Z","timestamp":1780316481141,"version":"3.54.1"},"reference-count":190,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,5,8]],"date-time":"2014-05-08T00:00:00Z","timestamp":1399507200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12640-014-9473-0","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T13:48:09Z","timestamp":1399470489000},"page":"400-413","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Neurodegenerative Aspects in Vulnerability to Schizophrenia Spectrum Disorders"],"prefix":"10.1007","volume":"26","author":[{"given":"Trevor","family":"Archer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serafino","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max Rapp","family":"Ricciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,8]]},"reference":[{"key":"9473_CR1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/schbul\/sbr133","volume":"38","author":"A Adell","year":"2012","unstructured":"Adell A, Jim\u00e9nez-S\u00e1nchez L, L\u00f3pez-Gil X, Rom\u00f3n T (2012) Is the acute NMDA receptor hypofunction a valid model of schizophrenia? Schizophr Bull 38:9\u201314","journal-title":"Schizophr Bull"},{"key":"9473_CR2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","volume":"389","author":"CA Altar","year":"1997","unstructured":"Altar CA, Cai N, Bliven T, Juhasz M, Conner JM et al (1997) Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 389:856\u2013860","journal-title":"Nature"},{"issue":"6","key":"9473_CR3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1192\/bjp.bp.110.079608","volume":"198","author":"N Aoyama","year":"2011","unstructured":"Aoyama N, Th\u00e9berge J, Drost DJ, Manchanda R, Northcott S, Neufeld RW, Menon RS, Rajakumar N, Pavlosky WF, Densmore M, Schaefer B, Williamson PC (2011) Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia. Br J Psychiatry 198(6):448\u2013456. doi: 10.1192\/bjp.bp.110.079608","journal-title":"Br J Psychiatry"},{"key":"9473_CR4","first-page":"1","volume":"17","author":"Y Aoyama","year":"2013","unstructured":"Aoyama Y, Mouri A, Toriumi K, Koseki T, Narusawa S, Ikawa N, Mamiya T, Nagai T, Yamada K, Nabeshima T (2013) Clozapine ameliorates epigenetic and behavioral abnormalities induced by phencyclidine through activation of dopamine D1 receptor. Int J Neuropsychopharmacol 17:1\u201315","journal-title":"Int J Neuropsychopharmacol"},{"issue":"Suppl 2","key":"9473_CR5","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1093\/schbul\/sbt198","volume":"40","author":"C Arango","year":"2013","unstructured":"Arango C, Fraguas D, Parellada M (2013) Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull 40(Suppl 2):S138\u2013S146","journal-title":"Schizophr Bull"},{"key":"9473_CR6","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1586\/ern.09.152","volume":"10","author":"T Archer","year":"2010","unstructured":"Archer T (2010) Neurodegeneration in schizophrenia. Expert Rev Neurother 10:1131\u20131141","journal-title":"Expert Rev Neurother"},{"key":"9473_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s12640-010-9162-6","volume":"18","author":"T Archer","year":"2010","unstructured":"Archer T, Kostrzewa RM, Beninger RJ, Palomo T (2010a) Staging perspectives in neurodevelopmental aspects of neuropsychiatry: agents, phases and ages at expression. Neurotox Res 18:287\u2013305","journal-title":"Neurotox Res"},{"key":"9473_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12640-010-9161-7","volume":"18","author":"T Archer","year":"2010","unstructured":"Archer T, Kostrzewa RM, Palomo T, Beninger RJ (2010b) Clinical staging in the pathophysiology of psychotic and affective disorders: facilitation of prognosis and treatment. Neurotox Res 18:211\u2013228","journal-title":"Neurotox Res"},{"key":"9473_CR9","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1152\/physrev.00024.2003","volume":"84","author":"J Avila","year":"2004","unstructured":"Avila J, Lucas JJ, Perez M, Hernandez F (2004) Role of tau protein in both physiological and pathological conditions. Physiol Rev 84:361\u2013384","journal-title":"Physiol Rev"},{"key":"9473_CR10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1515\/BC.2009.033","volume":"390","author":"N Ballatori","year":"2009","unstructured":"Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K et al (2009) Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 390:191\u2013214","journal-title":"Biol Chem"},{"issue":"1","key":"9473_CR11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-244X-13-326","volume":"13","author":"S Barbeito","year":"2013","unstructured":"Barbeito S, Vega P, Ruiz de Az\u00faa S, Saenz M, Martinez-Cengotitabengoa M, Gonz\u00e1lez-Ortega I, Bermudez C, Hernanz M, Corres BF, Gonz\u00e1lez-Pinto A (2013) Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study. BMC Psychiatry 13(1):326. doi: 10.1186\/1471-244X-13-326","journal-title":"BMC Psychiatry"},{"key":"9473_CR12","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1093\/hmg\/ddi331","volume":"14","author":"Z Berger","year":"2005","unstructured":"Berger Z, Ttofi EK, Michel CH, Pasco MY, Tenant S et al (2005) Lithium rescues toxicity of aggregate-prone proteins in Drosophila by perturbing Wnt pathway. Hum Mol Genet 14:3003\u20133011","journal-title":"Hum Mol Genet"},{"issue":"10","key":"9473_CR13","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.biopsych.2012.11.006","volume":"73","author":"V Bergink","year":"2013","unstructured":"Bergink V, Burgerhout KM, Weigelt K, Pop VJ, de Wit H, Drexhage RC, Kushner SA, Drexhage HA (2013a) Immune system dysregulation in first-onset postpartum psychosis. Biol Psychiatry 73(10):1000\u20131007. doi: 10.1016\/j.biopsych.2012.11.006","journal-title":"Biol Psychiatry"},{"key":"9473_CR14","author":"V Bergink","year":"2013","unstructured":"Bergink V, Gibney SM, Drexhage HA (2013b) Autoimmunity, inflammation and psychosis: a search for peripheral markers. Biol Psychiatry. doi: 10.1016\/j.biopsych.2013.09.037","journal-title":"Biol Psychiatry"},{"key":"9473_CR15","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1017\/S1461145711000502","volume":"14","author":"O Bergman","year":"2011","unstructured":"Bergman O, Westberg L, Lichtenstein P, Eriksson E, Larsson H (2011) Study on the possible association of brain-derived neurotrophic factor polymorphism with the developmental course of symptoms of attention deficit and hyperactivity. Int J Neuropsychopharmacol 14:1367\u20131376","journal-title":"Int J Neuropsychopharmacol"},{"key":"9473_CR16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/B978-0-12-800101-1.00013-2","volume":"121","author":"J Bloemer","year":"2014","unstructured":"Bloemer J, Bhattacharya S, Amin R, Suppiramaniam V (2014) Impaired insulin signaling and mechanisms of memory loss. Prog Mol Biol Transl Sci 121:413\u2013449. doi: 10.1016\/B978-0-12-800101-1.00013-2","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"2","key":"9473_CR17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1136\/jnnp.2005.069690","volume":"77","author":"SJ Borgwardt","year":"2006","unstructured":"Borgwardt SJ, Radue EW, Gotz K, Aston J, Drewe M, Gschwandtner U, Haller S, Pfluger M, Stieglitz RD, McGuire PK, Riecher-Rossler A (2006) Radiological findings in individuals at high risk of psychosis. J Neurol Neurosurg Psychiatry 77(2):229\u2013233","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"10","key":"9473_CR18","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.biopsych.2006.08.009","volume":"61","author":"SJ Borgwardt","year":"2007","unstructured":"Borgwardt SJ, Riecher-Rossler A, Dazzan P, Chitnis X, Aston J, Drewe M, Gschwandtner U, Haller S, Pfluger M, Rechsteiner E, D\u2019Souza M, Stieglitz RD, Radu EW, McGuire PK (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61(10):1148\u20131156","journal-title":"Biol Psychiatry"},{"issue":"3","key":"9473_CR19","first-page":"214","volume":"35","author":"S Borgwardt","year":"2010","unstructured":"Borgwardt S, Smieskova R, Bendfeldt K, Buhlmann E, Berger G, Aston J, Gschwandtner U, Pflueger M, Stieglitz RD, Riecher-Rossler A, Radue EW (2010) Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects? J Psychiatry Neurosci 35(3):214\u2013215 author reply 215","journal-title":"J Psychiatry Neurosci"},{"issue":"1\u20133","key":"9473_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2011.08.021","volume":"133","author":"S Borgwardt","year":"2011","unstructured":"Borgwardt S, McGuire P, Fusar-Poli P (2011) Gray matters!\u2013mapping the transition to psychosis. Schizophr Res 133(1\u20133):63\u201367","journal-title":"Schizophr Res"},{"issue":"11","key":"9473_CR21","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.jpsychires.2012.08.016","volume":"46","author":"M Borovcanin","year":"2012","unstructured":"Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Bankovic D, Arsenijevic N, Lukic ML (2012) Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse. J Psychiatr Res 46(11):1421\u20131426. doi: 10.1016\/j.jpsychires.2012.08.016","journal-title":"J Psychiatr Res"},{"issue":"1","key":"9473_CR22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2013.03.027","volume":"147","author":"M Borovcanin","year":"2013","unstructured":"Borovcanin M, Jovanovic I, Radosavljevic G, Djukic Dejanovic S, Stefanovic V, Arsenijevic N, Lukic ML (2013) Antipsychotics can modulate the cytokine profile in schizophrenia: attenuation of the type-2 inflammatory response. Schizophr Res 147(1):103\u2013109. doi: 10.1016\/j.schres.2013.03.027","journal-title":"Schizophr Res"},{"key":"9473_CR23","author":"M Bosia","year":"2011","unstructured":"Bosia M, Buonocure M, Guglielmino C, Pirovana A, Lorenzi C et al (2011) Saitohin polymorphism and executive dysfunction in schizophrenia. Neurol Sci. doi: 10.1007\/s10072-0893-9","journal-title":"Neurol Sci"},{"key":"9473_CR24","author":"MG Bossong","year":"2013","unstructured":"Bossong MG, Jansma JM, Bhattacharyya S, Ramsey NF (2013) Role of the endocannabinoid system in brain functions relevant for schizophrenia: an overview of human challenge studies with cannabis or \u22069-tetrahydrocannabinol (THC). Prog Neuropsychopharmacol Biol Psychiatry. doi: 10.1016\/j.pnpbp.2013.11.017","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9473_CR25","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/glia.20557","volume":"55","author":"AM Brown","year":"2007","unstructured":"Brown AM, Ransom BR (2007) Astrocyte glycogen and brain energy metabolism. Glia 55:1263\u20131271","journal-title":"Glia"},{"key":"9473_CR26","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.2003.042416","volume":"549","author":"AM Brown","year":"2003","unstructured":"Brown AM, Baltan Tekkok S, Ransom BR (2003) Glycogen regulation and functional role in mouse white matter. J Physiol 549:501\u2013512","journal-title":"J Physiol"},{"issue":"7","key":"9473_CR27","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpsychires.2009.10.008","volume":"44","author":"E Buehlmann","year":"2010","unstructured":"Buehlmann E, Berger GE, Aston J, Gschwandtner U, Pflueger MO, Borgwardt SJ, Radue EW, Riecher-R\u00f6ssler A (2010) Hippocampus abnormalities in at risk mental states for psychosis? A cross-sectional high resolution region of interest magnetic resonance imaging study. J Psychiatr Res 44(7):447\u2013453. doi: 10.1016\/j.jpsychires.2009.10.008","journal-title":"J Psychiatr Res"},{"key":"9473_CR28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1600-0897.2012.01110.x","volume":"67","author":"I Burd","year":"2012","unstructured":"Burd I, Balakrishnan B, Kannan S (2012) Models of fetal brain injury, intrauterine inflammation, and preterm birth. Am J Reprod Immunol 67:287\u2013294. doi: 10.1111\/j.1600-0897.2012.01110.x","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"9473_CR29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.schres.2010.09.022","volume":"125","author":"J B\u00fcschlen","year":"2011","unstructured":"B\u00fcschlen J, Berger GE, Borgwardt SJ, Aston J, Gschwandtner U, Pflueger MO, Kuster P, Rad\u00fc EW, Stieglitz RD, Riecher-R\u00f6ssler A (2011) Pituitary volume increase during emerging psychosis. Schizophr Res 125(1):41\u201348. doi: 10.1016\/j.schres.2010.09.022","journal-title":"Schizophr Res"},{"key":"9473_CR30","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/mp.2009.121","volume":"15","author":"JR Bustillo","year":"2010","unstructured":"Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, Hammond R, Brooks WM, Lauriello J (2010) 1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry 15:629\u2013636","journal-title":"Mol Psychiatry"},{"key":"9473_CR31","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1001\/archpsyc.59.5.449","volume":"59","author":"M Cannon","year":"2002","unstructured":"Cannon M, Caspi A, Moffitt TE (2002a) Evidence for early, specific, pandevelopment impairment in schizophreniform disorder: results from a longitudinal birth cohort. Arch Gen Psychiatry 59:449\u2013456","journal-title":"Arch Gen Psychiatry"},{"key":"9473_CR32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1176\/appi.ajp.159.7.1080","volume":"159","author":"M Cannon","year":"2002","unstructured":"Cannon M, Murray RM, Jones P (2002b) Obstetric complications and schizophrenia: past, present and future. Am J Psychiatry 159:1080\u20131092","journal-title":"Am J Psychiatry"},{"key":"9473_CR33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0014-4886(86)90275-X","volume":"94","author":"S Chen","year":"1986","unstructured":"Chen S, Hillman DE (1986) Selective ablation of neurons by methylazoxymethanol during pre- and postnatal brain development. Exp Neurol 94:103\u2013119","journal-title":"Exp Neurol"},{"key":"9473_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.psychres.2011.01.011","volume":"189","author":"CC Chen","year":"2011","unstructured":"Chen CC, Huang TL (2011) Effects of antipsychotics on the serum BDNF levels in schizophrenia. Psychiatry Res 189:327\u2013330","journal-title":"Psychiatry Res"},{"issue":"3","key":"9473_CR35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.psychres.2013.08.056","volume":"210","author":"S Chen","year":"2013","unstructured":"Chen S, Broqueres-You D, Yang G, Wang Z, Li Y, Wang N, Zhang X, Yang F, Tan Y (2013) Relationship between insulin resistance, dyslipidemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia. Psychiatry Res 210(3):825\u2013829. doi: 10.1016\/j.psychres.2013.08.056","journal-title":"Psychiatry Res"},{"issue":"2\u20133","key":"9473_CR36","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000346157","volume":"35","author":"LJ Chew","year":"2013","unstructured":"Chew LJ, Fusar-Poli P, Schmitz T (2013) Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci 35(2\u20133):102\u2013129. doi: 10.1159\/000346157","journal-title":"Dev Neurosci"},{"key":"9473_CR37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0165-3806(03)00092-0","volume":"142","author":"E Ciani","year":"2003","unstructured":"Ciani E, Frenquelli M, Contestabile A (2003) Developmental expression of the cell cycle and apoptosis controlling gene, Lotl, in the rat cerebellum and in cerebellar granule cells. Brain Res Dev Brain Res 142:193\u2013202","journal-title":"Brain Res Dev Brain Res"},{"key":"9473_CR38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1159\/000071000","volume":"16","author":"O Combarros","year":"2003","unstructured":"Combarros O, Rodero L, Infante J, Palacio E, Llorca J, Fern\u00e1ndez-Viadero C, Pe\u00f1a N, Berciano J (2003) Age-dependent association between the Q7R polymorphism in the Saitohin gene and sporadic Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 16:132\u2013135","journal-title":"Dement Geriatr Cogn Disord"},{"key":"9473_CR39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/YCO.0b013e3282f53132","volume":"21","author":"CU Correll","year":"2008","unstructured":"Correll CU, Schenk EM (2008) Tardive dyskinesias and new antipsychotics. Curr Opin Psychiatry 21:151\u2013156","journal-title":"Curr Opin Psychiatry"},{"issue":"12","key":"9473_CR40","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1002\/hbm.20834","volume":"30","author":"NA Crossley","year":"2009","unstructured":"Crossley NA, Mechelli A, Fusar-Poli P, Broome MR, Matthiasson P, Johns LC, Bramon E, Valmaggia L, Williams SC, McGuire PK (2009) Superior temporal lobe dysfunction and frontotemporal dysconnectivity in subjects at risk of psychosis and in first-episode psychosis. Hum Brain Mapp 30(12):4129\u20134137","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"9473_CR41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2174\/138161212799316235","volume":"18","author":"MR Dauvermann","year":"2012","unstructured":"Dauvermann MR, Mukherjee P, Moorhead WT, Stanfield AC, Fusar-Poli P, Lawrie SM, Whalley HC (2012) Relationship between gyrification and functional connectivity of the prefrontal cortex in subjects at high genetic risk of schizophrenia. Curr Pharm Des 18(4):434\u2013442","journal-title":"Curr Pharm Des"},{"key":"9473_CR42","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neuroimage.2013.01.063","volume":"73","author":"MR Dauvermann","year":"2013","unstructured":"Dauvermann MR, Whalley HC, Romaniuk L, Valton V, Owens DG, Johnstone EC, Lawrie SM, Moorhead TW (2013) The application of nonlinear Dynamic Causal Modelling for fMRI in subjects at high genetic risk of schizophrenia. Neuroimage 73:16\u201329. doi: 10.1016\/j.neuroimage.2013.01.063","journal-title":"Neuroimage"},{"issue":"1\u20133","key":"9473_CR43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.schres.2013.10.018","volume":"151","author":"GP Davis","year":"2013","unstructured":"Davis GP, Compton MT, Wang S, Levin FR, Blanco C (2013) Association between cannabis use, psychosis, and schizotypal personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Schizophr Res 151(1\u20133):197\u2013202. doi: 10.1016\/j.schres.2013.10.018","journal-title":"Schizophr Res"},{"key":"9473_CR44","author":"SM Monte de la","year":"2013","unstructured":"de la Monte SM, Tong M (2013) Brain metabolic dysfunction at the core of Alzheimer\u2019s disease. Biochem Pharmacol. doi: 10.1016\/j.bcp.2013.12.012","journal-title":"Biochem Pharmacol"},{"key":"9473_CR45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neulet.2011.05.027","volume":"499","author":"OM Dean","year":"2011","unstructured":"Dean OM, van den Buuse M, Berk M, Copolov DL, Mavros C, Bush AI (2011) N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and D-amphetamine-treated rats: relevance to schizophrenia and bipolar disorder. Neurosci Lett 499:149\u2013153","journal-title":"Neurosci Lett"},{"key":"9473_CR46","doi-asserted-by":"crossref","unstructured":"Deutsch SI, Rosse RB, Lakshman RM (2006) Dysregulation Prog Neuropsychopharmacol Biol Psychiatry. 30(8):1369\u201380. of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer\u2019s disease, frontotemporal dementia and schizophrenia with therapeutic implications","DOI":"10.1016\/j.pnpbp.2006.04.007"},{"key":"9473_CR47","doi-asserted-by":"crossref","unstructured":"Di Forti M, Sallis H, Allegri F, Trotta A, Ferraro L, Stilo SA, Marconi A, La Cascia C, Reis Marques T, Pariante C, Dazzan P, Mondelli V, Paparelli A, Kolliakou A, Prata D, Gaugrhan F, David AS, Morgan C, Sthal D, Khondoker M, Maccabe JH, Murray RM (2013) Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabisUsers. Schizophr Bull","DOI":"10.1093\/schbul\/sbt181"},{"key":"9473_CR48","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2012.06.010","volume":"31","author":"M Nicola Di","year":"2013","unstructured":"Di Nicola M, Cattaneo A, Hepgul N, Di Forti M, Aitchison KJ, Janiri L, Murray RM, Dazzan P, Pariante CM, Mondelli V (2013) Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav Immun 31:90\u201395. doi: 10.1016\/j.bbi.2012.06.010","journal-title":"Brain Behav Immun"},{"issue":"1\u20133","key":"9473_CR49","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.schres.2013.10.019","volume":"151","author":"DH Dimitrov","year":"2013","unstructured":"Dimitrov DH, Lee S, Yantis J, Valdez C, Paredes RM, Braida N, Velligan D, Walss-Bass C (2013) Differential correlations between inflammatory cytokines and psychopathology in veterans with schizophrenia: potential role for IL-17 pathway. Schizophr Res 151(1\u20133):29\u201335. doi: 10.1016\/j.schres.2013.10.019","journal-title":"Schizophr Res"},{"key":"9473_CR50","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.conb.2009.05.001","volume":"19","author":"KQ Do","year":"2009","unstructured":"Do KQ, Cabungal JH, Frank A, Steullet P, Cuenod M (2009) Redox dysregulation, neurodevelopment and schizophrenia. Curr Opin Neurobiol 19:220\u2013230","journal-title":"Curr Opin Neurobiol"},{"key":"9473_CR51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/BC.2003.059","volume":"384","author":"R Dringen","year":"2003","unstructured":"Dringen R, Hirrlinger J (2003) Glutathione pathways in the brain. Biol Chem 384:505\u2013516","journal-title":"Biol Chem"},{"issue":"2","key":"9473_CR52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","volume":"74","author":"A Egerton","year":"2013","unstructured":"Egerton A, Chaddock CA, Winton-Brown TT, Bloomfield MA, Bhattacharyya S, Allen P, McGuire PK, Howes OD (2013) Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort. Biol Psychiatry 74(2):106\u2013112. doi: 10.1016\/j.biopsych.2012.11.017","journal-title":"Biol Psychiatry"},{"key":"9473_CR53","author":"J Elia","year":"2011","unstructured":"Elia J, Laracy S, Allen J, Nissley-Tsiopinis J, Borgmann-Winter K (2011) Epigenetics: genetics versus life experiences. Curr Topics Behav Neurosci. doi: 10.1007\/7854_2011_144","journal-title":"Curr Topics Behav Neurosci"},{"key":"9473_CR54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0920-9964(97)00149-7","volume":"30","author":"BA Ellenbroek","year":"1998","unstructured":"Ellenbroek BA, van den Kroonenberg PT, Cools AR (1998) The effects of an early stressful life event on sensorimotor gating in adult rats. Schizophr Res 30:251\u2013260","journal-title":"Schizophr Res"},{"issue":"12","key":"9473_CR55","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.biopsych.2008.12.015","volume":"65","author":"LM Ellman","year":"2009","unstructured":"Ellman LM, Yolken RH, Buka SL, Torrey EF, Cannon TD (2009) Cognitive functioning prior to the onset of psychosis: the role of fetal exposure to serologically determined influenza infection. Biol Psychiatry 65(12):1040\u20131047. doi: 10.1016\/j.biopsych.2008.12.015","journal-title":"Biol Psychiatry"},{"key":"9473_CR56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ng1296","volume":"36","author":"ES Emamian","year":"2004","unstructured":"Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA (2004) Convergent evidence for impaired AKT1-GSK3 signaling in schizophrenia. Nat Genet 36:131\u2013137","journal-title":"Nat Genet"},{"issue":"Suppl","key":"9473_CR57","first-page":"93","volume":"13","author":"M Faizi","year":"2014","unstructured":"Faizi M, Salimi A, Rasoulzadeh M, Naserzadeh P, Pourahmad J (2014) Schizophrenia induces oxidative stress and cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration. Iran J Pharm Res 13(Suppl):93\u2013100","journal-title":"Iran J Pharm Res"},{"key":"9473_CR58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jpsychires.2011.09.022","volume":"46","author":"G Favalli","year":"2012","unstructured":"Favalli G, Li J, Belmonte-de-Abreu P, Wong AH, Daskalakis ZJ (2012) The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 46:1\u201311","journal-title":"J Psychiatr Res"},{"key":"9473_CR59","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/sj.npp.1301223","volume":"32","author":"RE Featherstone","year":"2007","unstructured":"Featherstone RE, Rizos Z, Nobrega JN, Kapur S, Fletcher PJ (2007) Gestational methylazoxymethanol acetate treatment impairs select cognitive functions: parallels to schizophrenia. Neuropsychopharmacology 32:483\u2013492","journal-title":"Neuropsychopharmacology"},{"key":"9473_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005072-199701000-00001","volume":"56","author":"I Ferrer","year":"1997","unstructured":"Ferrer I, Pozas E, Marti M, Blanco R, Planas AM (1997) Methylazoxymethanol-induced apoptosis in the external granule cell layer of the developing cerebellum of the rat is associated with strong c-jun expression and formation of high molecular weight c-jun complexes. J Neuropathol Exp Neurol 56:1\u20139","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"9473_CR61","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/01.wnr.0000135934.03635.6a","volume":"15","author":"M Fiore","year":"2004","unstructured":"Fiore M, Grace AA, Korf J, Stampachiacchiere B, Aloe L (2004) Impaired brain development in the rat following prenatal exposure to methylazoxymethanol acetate at gestational day 17 and neurotrophin distribution. NeuroReport 15(11):1791\u20131795","journal-title":"NeuroReport"},{"key":"9473_CR62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/sj.npp.1300625","volume":"30","author":"P Flagstad","year":"2005","unstructured":"Flagstad P, Glenthoj BY, Didriksen M (2005) Cognitive deficits caused by late gestational disruption of neurogenesis in rats: a preclinical model of schizophrenia. Neuropsychopharmacology 30:250\u2013260","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"9473_CR63","doi-asserted-by":"crossref","first-page":"e82606","DOI":"10.1371\/journal.pone.0082606","volume":"8","author":"DL Foley","year":"2013","unstructured":"Foley DL, Mackinnon A, Watts GF, Shaw JE, Magliano DJ, Castle DJ, McGrath JJ, Waterreus A, Morgan VA, Galletly CA (2013) Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender. PLoS ONE 8(12):e82606. doi: 10.1371\/journal.pone.0082606","journal-title":"PLoS ONE"},{"key":"9473_CR64","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1192\/bjp.bp.110.077479","volume":"198","author":"MA Fontes","year":"2011","unstructured":"Fontes MA, Bolla KI, Cunha PJ, Almeida PP, Jungerman F, Laranjeira RR, Bressan RA, Lacerda AL (2011) Cannabis use before age 15 and subsequent executive functioning. Br J Psychiatry 198:442\u2013447","journal-title":"Br J Psychiatry"},{"key":"9473_CR65","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0165-1781(98)00113-9","volume":"81","author":"T Furukawa","year":"1998","unstructured":"Furukawa T, Mizukawa R, Hirai T, Fujihara S, Kitamura T, Takahashi K (1998) Childhood parental loss and schizophrenia: evidence against pathogens but for some pathoplastic effects. Psychiatry Res 81:353\u2013362","journal-title":"Psychiatry Res"},{"issue":"1","key":"9473_CR66","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/schbul\/sbr111","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Meyer-Lindenberg A (2013a) Striatal presynaptic dopamine in schizophrenia, part I: meta-analysis of dopamine active transporter (DAT) density. Schizophr Bull 39(1):22\u201332. doi: 10.1093\/schbul\/sbr111","journal-title":"Schizophr Bull"},{"issue":"1","key":"9473_CR67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/schbul\/sbr180","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Meyer-Lindenberg A (2013b) Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [18F]\/[11C] DOPA PET studies. Schizophr Bull 39(1):33\u201342. doi: 10.1093\/schbul\/sbr180","journal-title":"Schizophr Bull"},{"issue":"4","key":"9473_CR68","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.neubiorev.2006.11.006","volume":"31","author":"P Fusar-Poli","year":"2007","unstructured":"Fusar-Poli P, Perez J, Broome M, Borgwardt S, Placentino A, Caverzasi E, Cortesi M, Veggiotti P, Politi P, Barale F, McGuire P (2007) Neurofunctional correlates of vulnerability to psychosis: a systematic review and meta-analysis. Neurosci Biobehav Rev 31(4):465\u2013484","journal-title":"Neurosci Biobehav Rev"},{"issue":"7","key":"9473_CR69","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/archgenpsychiatry.2010.77","volume":"67","author":"P Fusar-Poli","year":"2010","unstructured":"Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Grasby PM, McGuire PK (2010) Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry 67(7):683\u2013691. doi: 10.1001\/archgenpsychiatry.2010.77","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"9473_CR70","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neubiorev.2010.12.005","volume":"35","author":"P Fusar-Poli","year":"2011","unstructured":"Fusar-Poli P, Borgwardt S, Crescini A, D\u2019Este G, Kempton M, Lawrie S, Guire PM, Sacchetti E (2011a) Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 35(5):1175\u20131185","journal-title":"Neurosci Biobehav Rev"},{"issue":"9","key":"9473_CR71","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archgenpsychiatry.2011.46","volume":"68","author":"P Fusar-Poli","year":"2011","unstructured":"Fusar-Poli P, Stone JM, Broome MR, Valli I, Mechelli A, McLean MA, Lythgoe DJ, O\u2019Gorman RL, Barker GJ, McGuire PK (2011b) Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis. Arch Gen Psychiatry 68(9):881\u2013890. doi: 10.1001\/archgenpsychiatry.2011.46","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"9473_CR72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2009.108","volume":"16","author":"P Fusar-Poli","year":"2011","unstructured":"Fusar-Poli P, Howes OD, Allen P, Broome M, Valli I, Asselin MC, Montgomery AJ, Grasby PM, McGuire P (2011c) Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol Psychiatry 16(1):67\u201375","journal-title":"Mol Psychiatry"},{"issue":"3","key":"9473_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archgenpsychiatry.2011.1472","volume":"69","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton M, Barale F, Caverzasi E, McGuire P (2012a) Predicting psychosis: a meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69(3):1\u201310","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"9473_CR74","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1001\/archgenpsychiatry.2011.1592","volume":"69","author":"P Fusar-Poli","year":"2012","unstructured":"Fusar-Poli P, Deste G, Smieskova R, Barlati G, Yung AR, Howes O, Stieglitz R, McGuire P, Borgwardt S (2012b) Cognitive functioning in prodromal psychosis: a meta-analysis. Arch Gen Psychiatry 69(6):562\u2013571. doi: 10.1001\/archgenpsychiatry.2011.1592","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"9473_CR75","first-page":"107","volume":"70","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Borgwardt S, Bechdolf A, Addington J, Riecher-R\u00f6ssler A, Schultze-Lutter F, Keshavan M, Wood S, Ruhrmann S, Seidman L, Valmaggia L, Cannon T, Velthorst E, De Haan L, Cornblatt B, Birchwood M, McGlashan T, Carpenter W, McGorry P, Klosterk\u00f6tter J, McGuire P, Yung A (2013a) The psychosis high risk state: a comprehensive state of the art review. Arch Gen Psychiatry 70(1):107\u2013120. doi: 10.1001\/jamapsychiatry.2013.269","journal-title":"Arch Gen Psychiatry"},{"key":"9473_CR76","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Smieskova R, Kempton MJ, Ho BC, Andreasen NC, Borgwardt S (2013b) Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies. Neurosci Biobehav Rev. doi: 10.1016\/j.neubiorev.2013.06.001","journal-title":"Neurosci Biobehav Rev"},{"issue":"4","key":"9473_CR77","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/schbul\/sbs060","volume":"39","author":"P Fusar-Poli","year":"2013","unstructured":"Fusar-Poli P, Bechdolf A, Taylor M, Bonoldi I, Carpenter W, Yung A, McGuire P (2013c) At risk for schizophrenic or affective psychosis? A meta-analysis of ICD\/DSM diagnostic outcomes in individuals at high clinical risk. Schizophr Bull 39(4):923\u2013932. doi: 10.1093\/schbul\/sbs060","journal-title":"Schizophr Bull"},{"issue":"8","key":"9473_CR78","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/0004867412453089","volume":"46","author":"CA Galletly","year":"2012","unstructured":"Galletly CA, Foley DL, Waterreus A, Watts GF, Castle DJ, McGrath JJ, Mackinnon A, Morgan VA (2012) Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis. Aust N Z J Psychiatry 46(8):753\u2013761. doi: 10.1177\/0004867412453089","journal-title":"Aust N Z J Psychiatry"},{"key":"9473_CR79","author":"A Garakani","year":"2013","unstructured":"Garakani A, Welch AK, Jaffe RJ, Protin CA, McDowell DM (2013) Psychosis and low cyanocobalamin in a patient abusing nitrous oxide and cannabis. Psychosomatics. doi: 10.1016\/j.psym.2013.11.001","journal-title":"Psychosomatics"},{"key":"9473_CR80","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/oxfordjournals.schbul.a033389","volume":"25","author":"JR Geddes","year":"1999","unstructured":"Geddes JR, Verdoux H, Takei N (1999) Schizophrenia and complications of pregnancy and labour: an individual patient data meta-analysis. Schizophrenia Bull 25:413\u2013423","journal-title":"Schizophrenia Bull"},{"issue":"3","key":"9473_CR81","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12035-013-8404-z","volume":"47","author":"R Ghasemi","year":"2012","unstructured":"Ghasemi R, Dargahi L, Haeri A, Moosavi M, Mohamed Z, Ahmadiani A (2012) Brain insulin dysregulation: implication for neurological and neuropsychiatric disorders. Mol Neurobiol 47(3):1045\u20131065. doi: 10.1007\/s12035-013-8404-z","journal-title":"Mol Neurobiol"},{"key":"9473_CR82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/glia.20377","volume":"54","author":"ME Gibbs","year":"2006","unstructured":"Gibbs ME, Anderson DG, Hertz L (2006) Inhibition of glycogenolysis in astrocytes interrupts memory consolidation in young chickens. Glia 54:214\u2013222","journal-title":"Glia"},{"key":"9473_CR83","author":"KE Gill","year":"2013","unstructured":"Gill KE, Poe L, Azimov N, Ben-David S, Vadhan NP, Girgis R, Moore H, Cressman V, Corcoran CM (2013) Reasons for cannabis use among youths at ultra high risk for psychosis. Early Interv Psychiatry. doi: 10.1111\/eip.12112","journal-title":"Early Interv Psychiatry"},{"key":"9473_CR84","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1001\/archgenpsychiatry.2009.24","volume":"66","author":"AL Goldman","year":"2009","unstructured":"Goldman AL, Pezawas L, Mattay VS, Fischl B, Verchinski BA, Chen Q, Weinberger DR, Meyer-Lindenberg A (2009) Widespread reductions of cortical thickness in schizophrenia and spectrum disorders and evidence of heritability. Arch Gen Psychiatry 66:467\u2013477","journal-title":"Arch Gen Psychiatry"},{"key":"9473_CR85","first-page":"1","volume":"4","author":"R Gomez-Sintes","year":"2011","unstructured":"Gomez-Sintes R, Hernandez F, Lucas JJ, Avila J (2011) GSK-3 mouse models to study neuronal apoptosis and neurodegeneration. Fron Mol Neurosci 4:1\u201311. doi: 10.3389\/fnmol.2011.00045","journal-title":"Fron Mol Neurosci"},{"key":"9473_CR86","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopsych.2006.05.046","volume":"60","author":"Y Goto","year":"2006","unstructured":"Goto Y, Grace AA (2006) Alterations in medial prefrontal cortical activity and plasticity in rats with disruption of cortical development. Boil psychiatry 60:1259\u20131267","journal-title":"Boil psychiatry"},{"key":"9473_CR87","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.eurpsy.2009.10.001","volume":"26","author":"N Goto","year":"2010","unstructured":"Goto N, Yoshimura R, Kakeda S, Moriya J, Hayashi K, Ikenouchi-Sugita A, Umene-Nakano W, Hori H, Ueda N, Korogi Y, Nakamura J (2010) Comparison of brain N-acetylaspartate levels and serum brain-derived neurotrophic factor (BDNF) levels between patients with first-episode schizophrenia psychosis and healthy controls. Eur Psychiatry 26:57\u201363","journal-title":"Eur Psychiatry"},{"key":"9473_CR88","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.fbp.0000135703.48799.71","volume":"15","author":"R Gourevitch","year":"2004","unstructured":"Gourevitch R, Rocher C, Le Pen G, Krebs MO, Jay TM (2004) Working memory deficits in adult rats after prenatal disruption of neurogenesis. Behav Pharmacol 15:287\u2013292","journal-title":"Behav Pharmacol"},{"key":"9473_CR89","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1152\/physrev.00012.2010","volume":"91","author":"J Graff","year":"2011","unstructured":"Graff J, Dohoon K, Dobbin MM, Tsai LH (2011) Epigenetic regulation of gene expression in physiological and pathological brain processes. Physiol Rev 91:603\u2013649","journal-title":"Physiol Rev"},{"issue":"1\u20133","key":"9473_CR90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.schres.2007.12.476","volume":"101","author":"KA Graham","year":"2008","unstructured":"Graham KA, Cho H, Brownley KA, Harp JB (2008) Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects. Schizophr Res 101(1\u20133):287\u2013294. doi: 10.1016\/j.schres.2007.12.476","journal-title":"Schizophr Res"},{"key":"9473_CR91","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.biopsych.2006.08.025","volume":"61","author":"M Gratacos","year":"2007","unstructured":"Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X (2007) Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders and schizophrenia. Biol Psychiatry 61:911\u2013922","journal-title":"Biol Psychiatry"},{"key":"9473_CR92","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jpsychires.2006.01.005","volume":"41","author":"RW Grillo","year":"2007","unstructured":"Grillo RW, Ottoni GL, Leke R, Souza DO, Portela LV, Lara DR (2007) Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics. J Psychiatry Res 41:31\u201335","journal-title":"J Psychiatry Res"},{"issue":"1","key":"9473_CR93","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1148\/radiol.2501072153","volume":"250","author":"S Haller","year":"2009","unstructured":"Haller S, Borgwardt SJ, Schindler C, Aston J, Radue EW, Riecher-R\u00f6ssler A (2009) Can cortical thickness asymmetry analysis contribute to detection of at-risk mental state and first-episode psychosis? A pilot study. Radiology 250(1):212\u2013221. doi: 10.1148\/radiol.2501072153","journal-title":"Radiology"},{"key":"9473_CR94","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.brainres.2003.09.044","volume":"994","author":"L Hertz","year":"2003","unstructured":"Hertz L, O\u2019Dowd BS, Ng KT, Gibbs ME (2003) Reciprocal changes in forebrain contents of glycogen and glutamate\/glutamate during early memory consolidation in the day-old chick. Brain Res 994:226\u2013233","journal-title":"Brain Res"},{"key":"9473_CR95","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ajmg.b.30957","volume":"153B","author":"J Hoenicka","year":"2010","unstructured":"Hoenicka J, Garrido E, Mart\u00ednez I, Ponce G, Arag\u00fc\u00e9s M, Rodr\u00edguez-Jim\u00e9nez R, Espa\u00f1a-Serrano L, Alvira-Botero X, Santos JL, Rubio G, Jim\u00e9nez-Arriero MA, Palomo T, PARGPARG (2010) Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet 153B:79\u201385","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"9473_CR96","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.biopsych.2007.05.027","volume":"63","author":"RA Honea","year":"2008","unstructured":"Honea RA, Meyer-Lindenberg A, Hobbs KB, Pezawas L, Mattay VS, Egan MF, Verchinski B, Passingham RE, Weinberger DR, Callicott JH (2008) Is grey matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometric study of patients with schizophrenia and their healthy siblings. Biol Psychiatry 63:465\u2013474","journal-title":"Biol Psychiatry"},{"issue":"1\u20133","key":"9473_CR97","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.schres.2012.12.023","volume":"145","author":"S Hope","year":"2013","unstructured":"Hope S, Ueland T, Steen NE, Dieset I, Lorentzen S, Berg AO, Agartz I, Aukrust P, Andreassen OA (2013) Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder. Schizophr Res 145(1\u20133):36\u201342. doi: 10.1016\/j.schres.2012.12.023","journal-title":"Schizophr Res"},{"key":"9473_CR98","doi-asserted-by":"crossref","first-page":"s13","DOI":"10.1192\/bjp.191.51.s13","volume":"s51","author":"OD Howes","year":"2007","unstructured":"Howes OD, Montgomery AJ, Asselin M, Murray R, Grasby P, McGuire P (2007) Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry s51:s13\u2013s18","journal-title":"Br J Psychiatry"},{"issue":"2","key":"9473_CR99","first-page":"115","volume":"33","author":"CC Huang","year":"2010","unstructured":"Huang CC, Lee CC (2010) Hsu KS (2010) The role of insulin receptor signaling in synaptic plasticity and cognitive function. Chang Gung Med J 33(2):115\u2013125","journal-title":"Chang Gung Med J"},{"issue":"1","key":"9473_CR100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.biopsych.2007.04.017","volume":"63","author":"J Huttunen","year":"2008","unstructured":"Huttunen J, Heinimaa M, Svirskis T, Nyman M, Kajander J, Forsback S, Solin O, Ilonen T, Korkeila J, Ristkari T, McGlashan T, Salokangas RK, Hietala J (2008) Striatal dopamine synthesis in first-degree relatives of patients with schizophrenia. Biol Psychiatry 63(1):114\u2013117","journal-title":"Biol Psychiatry"},{"key":"9473_CR101","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/350230a0","volume":"350","author":"C Hyman","year":"1991","unstructured":"Hyman C, Hofer M, Barde YA, Juhasz M, Yancopoulos GD, Squinto SP, Lindsay RM (1991) BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230\u2013232","journal-title":"Nature"},{"key":"9473_CR102","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.schres.2008.01.017","volume":"101","author":"Y Ikeda","year":"2008","unstructured":"Ikeda Y, Yahata N, Ito I, Nagano M, Toyota T et al (2008) Low serum levels of brain derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia. Schizophr Res 101:58\u201366","journal-title":"Schizophr Res"},{"key":"9473_CR103","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1086\/598822","volume":"84","author":"E Jablonka","year":"2009","unstructured":"Jablonka E, Raz G (2009) Transgenerational epigenetic inheritance: prevalence, mechanisms, and implications for the study of heredity and evolution. Q Rev Biol 84:131\u2013176","journal-title":"Q Rev Biol"},{"key":"9473_CR104","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00406-009-0079-0","volume":"260","author":"CP Jacob","year":"2010","unstructured":"Jacob CP, Nguyen TT, Dempfle A, Heine M, Windemuth-Kieselbach C, Baumann K, Jacob F, Prechtl J, Wittlich M, Herrmann MJ, Gross-Lesch S, Lesch KP, Reif A (2010) A gene-environment investigation on personality traits in two independent clinical sets of adult patients with personality disorder and attention deficit\/hyperactivity disorder. Eur Arch Psychiatr Clin Neurosci 260:317\u2013326","journal-title":"Eur Arch Psychiatr Clin Neurosci"},{"key":"9473_CR105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1471-4159.2011.07590.x","volume":"120","author":"S Jafari","year":"2012","unstructured":"Jafari S, Fernandez-Enright F, Huang XF (2012) Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects. J Neurochem 120:371\u2013384","journal-title":"J Neurochem"},{"issue":"7376","key":"9473_CR106","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1038\/nature10615","volume":"480","author":"T Jaworski","year":"2011","unstructured":"Jaworski T, Dewachter I, Lechat B, Gees M, Kremer A, Demedts D, Borghgraef P, Devijver H, K\u00fcgler S, Patel S, Woodgett JR, Van Leuven F (2011) GSK-3\u03b1\/\u03b2 kinases and amyloid production in vivo. Nature 480(7376):E4\u2013E5","journal-title":"Nature"},{"key":"9473_CR107","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fnins.2013.00110","volume":"7","author":"TA Jenkins","year":"2013","unstructured":"Jenkins TA (2013) Perinatal complications and schizophrenia: involvement of the immune system. Front Neurosci 7:110. doi: 10.3389\/fnins.2013.00110","journal-title":"Front Neurosci"},{"key":"9473_CR108","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3389\/fnmol.2011.00040","volume":"4","author":"O Kaidanovich-Beilin","year":"2011","unstructured":"Kaidanovich-Beilin O, Woodgett JR (2011) GSK-3: functional insights from cell biology and animal models. Front Mol Neurosci 4:40","journal-title":"Front Mol Neurosci"},{"issue":"3","key":"9473_CR109","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archgenpsychiatry.2010.10","volume":"67","author":"LS Kegeles","year":"2010","unstructured":"Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, Hwang DR, Huang Y, Haber SN, Laruelle M (2010) Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 67(3):231\u2013239","journal-title":"Arch Gen Psychiatry"},{"key":"9473_CR110","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/epi.12.20","volume":"4","author":"JB Kirkbride","year":"2012","unstructured":"Kirkbride JB, Susser E, Kundakovic M, Kresovich JK, Davey Smith G, Relton CL (2012) Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? Epigenomics 4:303\u2013315","journal-title":"Epigenomics"},{"issue":"6","key":"9473_CR111","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","volume":"39","author":"B Kirkpatrick","year":"2013","unstructured":"Kirkpatrick B, Miller BJ (2013) Inflammation and schizophrenia. Schizophr Bull 39(6):1174\u20131179. doi: 10.1093\/schbul\/sbt141","journal-title":"Schizophr Bull"},{"issue":"6","key":"9473_CR112","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1093\/schbul\/sbr145","volume":"38","author":"N Koutsouleris","year":"2012","unstructured":"Koutsouleris N, Borgwardt S, Meisenzahl EM, Bottlender R, Moller HJ, Riecher-Rossler A (2012) Disease prediction in the At-risk mental State for psychosis using neuroanatomical biomarkers: results from the FePsy Study. Schizophr Bull 38(6):1234\u20131246. doi: 10.1093\/schbul\/sbr145","journal-title":"Schizophr Bull"},{"key":"9473_CR113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s004410050849","volume":"289","author":"M Lafarga","year":"1997","unstructured":"Lafarga M, Lerga A, Andres MA, Polanco JL, Calle E, Berciano MT (1997) Apoptosis induced by methylazoxymethanol in developing rat cerebellum: organization of the cell nucleus and its relationship to DNA and tRNA degradation. Cell Tissue Res 289:25\u201338","journal-title":"Cell Tissue Res"},{"issue":"17","key":"9473_CR114","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D\u2019Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93(17):9235\u20139240","journal-title":"Proc Natl Acad Sci USA"},{"key":"9473_CR115","doi-asserted-by":"crossref","first-page":"e22875","DOI":"10.1371\/journal.pone.0022875","volume":"6","author":"S Lavoie","year":"2011","unstructured":"Lavoie S, Allaman I, Petit JM, Do KQ, Magistretti PJ (2011) Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit: relevance for neuroenergetics in schizophrenia. PLoS ONE 6:e22875","journal-title":"PLoS ONE"},{"key":"9473_CR116","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/JCP.0b013e31821895c1","volume":"31","author":"AH Lee","year":"2011","unstructured":"Lee AH, Lange C, Ricken R, Hellweg R, Lang UE (2011) Reduced brain-derived neurotrophic factor serum concentrations in acute schizophrenic patients increase during antipsychotic treatment. J Clin Psychopharmacol 31:334\u2013336","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"9473_CR117","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.bbr.2005.02.016","volume":"161","author":"A Leng","year":"2005","unstructured":"Leng A, Jongen-R\u00ealo AL, Pothuizen HH, Feldon J (2005) Effects of prenatal methylazoxymethanol acetate (MAM) treatment in rats on water maze performance. Behav Brain Res 161(2):291\u2013298","journal-title":"Behav Brain Res"},{"issue":"1","key":"9473_CR118","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/schbul\/16.1.97","volume":"16","author":"JA Lieberman","year":"1990","unstructured":"Lieberman JA, Kinon BJ, Loebel AD (1990) Dopaminergic mechanisms in idiopathic and drug-induced psychoses. Schizophr Bull 16(1):97\u2013110","journal-title":"Schizophr Bull"},{"issue":"4","key":"9473_CR119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0893-133X(97)00045-6","volume":"17","author":"JA Lieberman","year":"1997","unstructured":"Lieberman JA, Sheitman BB, Kinon BJ (1997) Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 17(4):205\u2013229","journal-title":"Neuropsychopharmacology"},{"key":"9473_CR120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s007020050150","volume":"106","author":"SM Lillrank","year":"1999","unstructured":"Lillrank SM, Lipska BK, Kolachana BS, Weinberger DR (1999) Attenuated extracellular dopamine levels after stress and amphetamine in the nucleus accumbens of rats with neonatal ventral hippocampal damage. J Neural Transm 106:183\u2013196","journal-title":"J Neural Transm"},{"key":"9473_CR121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.schres.2010.08.022","volume":"123","author":"PL Lin","year":"2010","unstructured":"Lin PL, Shuldiner AR (2010) Rethinking the genetic basis of comorbidity of schizophrenia and type 2 diabetes. Schizophrenia Res 123:234\u2013243. doi: 10.1016\/j.schres.2010.08.022","journal-title":"Schizophrenia Res"},{"key":"9473_CR122","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/npp.1994.22","volume":"10","author":"BK Lipska","year":"1994","unstructured":"Lipska BK, Weinberger DR (1994) Subchronic treatment with haloperidol and clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 10:199\u2013205","journal-title":"Neuropsychopharmacology"},{"key":"9473_CR123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-8993(92)91184-G","volume":"585","author":"BK Lipska","year":"1992","unstructured":"Lipska BK, Jaskiw GE, Chrapusta S, Karoum F, Weinberger DR (1992) Ibotenic acid lesions of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res 585:1\u20136","journal-title":"Brain Res"},{"key":"9473_CR124","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02246439","volume":"122","author":"BK Lipska","year":"1995","unstructured":"Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995) Neonatal excitotoxic lesions hippocampal damage in rats causes post pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122:35\u201343","journal-title":"Psychopharmacology"},{"key":"9473_CR125","first-page":"47","volume":"49","author":"BK Lipska","year":"2001","unstructured":"Lipska BK, Kolb B, Halim N, Weinberger DR (2001) Synaptic abnormalities in prefrontal cortex and nucleus accumbens of adult rats with neonatal hippocampal damage. Schizophr Res 49:47\u201351","journal-title":"Schizophr Res"},{"key":"9473_CR126","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03033801","volume":"14","author":"DJ Lodge","year":"2008","unstructured":"Lodge DJ, Grace AA (2008) Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia. Neurotox Res 14:97\u2013104","journal-title":"Neurotox Res"},{"issue":"1","key":"9473_CR127","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/schbul\/sbp010","volume":"37","author":"GJ Lyon","year":"2011","unstructured":"Lyon GJ, Abi-Dargham A, Moore H, Lieberman JA, Javitch JA, Sulzer D (2011) Presynaptic regulation of dopamine transmission in schizophrenia. Schizophr Bull 37(1):108\u2013117","journal-title":"Schizophr Bull"},{"issue":"1\u20133","key":"9473_CR128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.schres.2012.02.017","volume":"137","author":"A Maat","year":"2012","unstructured":"Maat A, Fett AK, Derks E, GROUP Investigators (2012) Social cognition and quality of life in schizophrenia. Schizophr Res 137(1\u20133):212\u2013218. doi: 10.1016\/j.schres.2012.02.017","journal-title":"Schizophr Res"},{"issue":"2","key":"9473_CR129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tips.2007.11.005","volume":"29","author":"P McGuire","year":"2008","unstructured":"McGuire P, Howes OD, Stone J, Fusar-Poli P (2008) Functional neuroimaging in schizophrenia: diagnosis and drug discovery. Trends Pharmacol Sci. 29(2):91\u201398","journal-title":"Trends Pharmacol Sci."},{"issue":"5","key":"9473_CR130","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archgenpsychiatry.2011.42","volume":"68","author":"A Mechelli","year":"2011","unstructured":"Mechelli A, Riecher-Rossler A, Meisenzahl EM, Tognin S, Wood SJ, Borgwardt SJ, Koutsouleris N, Yung AR, Stone JM, Phillips LJ, McGorry PD, Valli I, Velakoulis D, Woolley J, Pantelis C, McGuire P (2011) Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study. Arch Gen Psychiatry. 68(5):489\u2013495","journal-title":"Arch Gen Psychiatry."},{"key":"9473_CR131","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.pneurobio.2011.07.007","volume":"95","author":"A Meyer-Lindenberg","year":"2011","unstructured":"Meyer-Lindenberg A (2011) Neuroimaging and the question of neurodegeneration in schizophrenia. Prog Neurobiol 95:514\u2013516","journal-title":"Prog Neurobiol"},{"issue":"3","key":"9473_CR132","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","volume":"5","author":"A Meyer-Lindenberg","year":"2002","unstructured":"Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M, Weinberger DR, Berman KF (2002) Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 5(3):267\u2013271","journal-title":"Nat Neurosci"},{"key":"9473_CR133","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archpsyc.62.4.379","volume":"62","author":"A Meyer-Lindenberg","year":"2005","unstructured":"Meyer-Lindenberg A, Olsen RK, Kohn PD, Brown T, Egan MF, Weinberger DR, Berman KF (2005) Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in Schizophrenia. Arch Gen Psychiatry 62:379\u2013386","journal-title":"Arch Gen Psychiatry"},{"key":"9473_CR134","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0006-3223(93)90044-E","volume":"34","author":"R Miller","year":"1993","unstructured":"Miller R, Chouinard G (1993) Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia. Biol Psychiatry 34:713\u2013738","journal-title":"Biol Psychiatry"},{"key":"9473_CR135","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pscychresns.2008.10.001","volume":"173","author":"J Miller","year":"2009","unstructured":"Miller J, Williamson P, Jensen JE, Manchanda R, Menon R et al (2009) Longitudinal 4.0 Testa (31)P magnetic resonance spectroscopy changes in the anterior cingulate and left thalamus in first episode schizophrenia. Psychiatr Res Neuroimaging 173:155\u2013157","journal-title":"Psychiatr Res Neuroimaging"},{"issue":"2","key":"9473_CR136","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1755-5949.2010.00230.x","volume":"17","author":"N Miyake","year":"2011","unstructured":"Miyake N, Thompson J, Skinbjerg M, Abi-Dargham A (2011) Presynaptic dopamine in schizophrenia. CNS Neurosci Ther 17(2):104\u2013109. doi: 10.1111\/j.1755-5949.2010.00230.x","journal-title":"CNS Neurosci Ther"},{"key":"9473_CR137","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/0091-3057(86)90445-4","volume":"24","author":"AK Mohammed","year":"1986","unstructured":"Mohammed AK, Jonsson G, S\u00f6derberg U, Archer T (1986a) Impaired selective attention in methylazoxymethanol-induced microencephalic rats. Pharmacol Biochem Behav 24:975\u2013981","journal-title":"Pharmacol Biochem Behav"},{"key":"9473_CR138","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-3806(86)90106-9","volume":"30","author":"AK Mohammed","year":"1986","unstructured":"Mohammed AK, Jonsson G, Sundstr\u00f6m E, Minor BG, S\u00f6derberg U, Archer T (1986b) Selective attention and place navigation in rats treated prenatally with methylazoxymethanol. Brain Res Dev Brain Res 30:145\u2013155","journal-title":"Brain Res Dev Brain Res"},{"key":"9473_CR139","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.biopsych.2006.01.003","volume":"60","author":"H Moore","year":"2006","unstructured":"Moore H, Jentsch JD, Ghajarnia M, Geyer MA, Grace AA (2006) A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia. Biol Psychiatry 60:253\u2013264","journal-title":"Biol Psychiatry"},{"key":"9473_CR140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1017\/S0033291706009330","volume":"37","author":"C Morgan","year":"2007","unstructured":"Morgan C, Kirkbride J, Leff J, Craig T, Hutchinson G, McKenzie K, Morgan K, Dazzan P, Doody GA, Jones P, Murray R, Fearon P (2007) Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychol Med 37:495\u2013503","journal-title":"Psychol Med"},{"key":"9473_CR141","first-page":"1","volume":"23","author":"VA Morgan","year":"2013","unstructured":"Morgan VA, McGrath JJ, Jablensky A, Badcock JC, Waterreus A, Bush R, Carr V, Castle D, Cohen M, Galletly C, Harvey C, Hocking B, McGorry P, Neil AL, Saw S, Shah S, Stain HJ, Mackinnon A (2013) Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med 23:1\u201314","journal-title":"Psychol Med"},{"key":"9473_CR142","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.pnpbp.2011.09.004","volume":"35","author":"T Niitsu","year":"2011","unstructured":"Niitsu T, Shirayama Y, Matsuzawa D, Hasegawa T, Kanahara N, Hashimoto T, Shiraishi T, Shiina A, Fukami G, Fujisaki M, Watanabe H, Nakazato M, Asano M, Kimura S, Hashimoto K, Iyo M (2011) Associations of serum brain-derived neurotrophic factor with cognitive impairments and negative symptoms in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35:1836\u20131840","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"7","key":"9473_CR143","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1097\/NEN.0b013e318222b97b","volume":"70","author":"C Niu","year":"2011","unstructured":"Niu C, Yip HK (2011) Neuroprotective signaling mechanisms of telomerase are regulated by brain-derived neurotrophic factor in rat spinal cord motor neurons. J Neuropathol Exp Neurol 70(7):634\u2013652","journal-title":"J Neuropathol Exp Neurol"},{"key":"9473_CR144","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1093\/cercor\/12.9.975","volume":"12","author":"P O\u2019Donnell","year":"2002","unstructured":"O\u2019Donnell P, Lewis BL, Weinberger DR, Lipska BK (2002) Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons in adult rats. Cereb Cortex 12:975\u2013982","journal-title":"Cereb Cortex"},{"key":"9473_CR145","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1471-4159.2011.07532.x","volume":"119","author":"T Onishi","year":"2011","unstructured":"Onishi T, Iwashita H, Uno Y, Kunitomo J, Saitoh M, Kimura E, Fujita H, Uchiyama N, Kori M, Takizawa M (2011) A novel glycogen synthase kinase-3 inhibitor 2-methyl-5-(3-{4-[(S\u200a)-methylsulfinyl]phenyl}-1-benzofuran-5-yl)-1,3,4-oxadiazole decreases tau phosphorylation and ameliorates cognitive deficits in a transgenic model of Alzheimer\u2019s disease. J Neurochem 119:1330\u20131340","journal-title":"J Neurochem"},{"issue":"1","key":"9473_CR146","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000327605","volume":"65","author":"CU Pae","year":"2012","unstructured":"Pae CU, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Serretti A, De Ronchi D (2012) Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology 65(1):1\u201311","journal-title":"Neuropsychobiology"},{"key":"9473_CR147","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.schres.2006.05.028","volume":"6","author":"A Palomino","year":"2006","unstructured":"Palomino A, Vallejo-Illarramendi A, Gonzalez-Pinto A, Aldama A, Gonzalez-Gomez C, Mosquera F, Gonzalez-Garcia G, Matute C (2006) Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients. Schizophr Res 6:321\u2013322","journal-title":"Schizophr Res"},{"key":"9473_CR148","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1440-1819.2009.01976.x","volume":"63","author":"SW Park","year":"2009","unstructured":"Park SW, Lee JG, Kong BG, Lee SJ, Lee CH, Kim JI, Kim YH (2009) Genetic association of BDNF val66met and GSK-3beta-50T\/C polymorphisms with tardive dyskinesia. Psychiatry Clin Neurosci 63:433\u2013439","journal-title":"Psychiatry Clin Neurosci"},{"issue":"48","key":"9473_CR149","doi-asserted-by":"crossref","first-page":"17365","DOI":"10.1523\/JNEUROSCI.2904-12.2012","volume":"32","author":"O Pasternak","year":"2012","unstructured":"Pasternak O, Westin CF, Bouix S, Seidman LJ, Goldstein JM, Woo TU, Petryshen TL, Mesholam-Gately RI, McCarley RW, Kikinis R, Shenton ME, Kubicki M (2012) Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci 32(48):17365\u201317372. doi: 10.1523\/JNEUROSCI.2904-12.2012","journal-title":"J Neurosci"},{"key":"9473_CR150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neulet.2011.01.039","volume":"491","author":"M Pedrini","year":"2011","unstructured":"Pedrini M, Chendo I, Grande I, Lobato MI, Belmonte-de-Abreu PS et al (2011) Serum brain-derived neurotrophic factor and clozapine daily dose in patients with schizophrenia, a positive correlation. Neurosci Lett 491:207\u2013210","journal-title":"Neurosci Lett"},{"issue":"Pt 3","key":"9473_CR151","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1348\/1476083041839402","volume":"77","author":"L Pert","year":"2004","unstructured":"Pert L, Ferriter M, Saul C (2004) Parental loss before the age of 16\u00a0years: a comparative study of patients with personality disorder and patients with schizophrenia in a high secure hospital\u2019s population. Psychol Psychother 77(Pt 3):403\u2013407","journal-title":"Psychol Psychother"},{"issue":"3","key":"9473_CR152","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.neuropharm.2011.01.049","volume":"62","author":"SB Powell","year":"2012","unstructured":"Powell SB, Sejnowski TJ, Behrens MM (2012) Behavioral and neurochemical consequences of cortical oxidative stress on parvalbumin-interneuron maturation in rodent models of schizophrenia. Neuropharmacology 62(3):1322\u20131331. doi: 10.1016\/j.neuropharm.2011.01.049","journal-title":"Neuropharmacology"},{"key":"9473_CR153","author":"S Ricci","year":"2013","unstructured":"Ricci S, Businaro R, Massoni F, Ippoliti F, Troili GM, Pontecorvi V, Morelli M, Rapp Ricciardi M, Archer T (2013) Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res. doi: 10.1007\/s12640-013-9393-4","journal-title":"Neurotox Res"},{"issue":"Suppl. 3","key":"9473_CR154","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.00108s3511","volume":"108","author":"D Rice","year":"2000","unstructured":"Rice D, Barone S (2000) Critical periods of vulnerability for the developing nervous system: evidence from human and animal models. Environment Health Perspect 108(Suppl. 3):511\u2013533","journal-title":"Environment Health Perspect"},{"key":"9473_CR155","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.pnpbp.2008.04.007","volume":"32","author":"EN Rizos","year":"2008","unstructured":"Rizos EN, Rontos I, Laskos E, Arsenis G, Michalopoulos PG et al (2008) Investigation of serum BDNF levels in drug-naive patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32:1308\u20131311","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9473_CR156","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/15622970802182733","volume":"1","author":"EN Rizos","year":"2010","unstructured":"Rizos EN, Papadopoulou A, Laskos E, Michalopoulos PG, Kastania D et al (2010) Reduced serum BDNF levels in patients with chronic schizophrenic disorder in relapse, who were treated with typical or atypical antipsychotics. World J Biol Psychiatry 1:251\u2013255","journal-title":"World J Biol Psychiatry"},{"key":"9473_CR157","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1176\/appi.ps.58.2.245","volume":"58","author":"SD Rosenberg","year":"2007","unstructured":"Rosenberg SD, Lu W, Mueser KT, Jankowski MK, Cournos F (2007) Correlates of adverse childhood events among adults with schizophrenia spectrum disorders. Psychiatr Serv 58:245\u2013253","journal-title":"Psychiatr Serv"},{"issue":"4","key":"9473_CR158","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/138161212799316316","volume":"18","author":"M Rothlisberger","year":"2012","unstructured":"Rothlisberger M, Riecher-Rossler A, Aston J, Fusar-Poli P, Radu EW, Borgwardt S (2012) Cingulate volume abnormalities in emerging psychosis. Curr Pharm Des 18(4):495\u2013504","journal-title":"Curr Pharm Des"},{"key":"9473_CR159","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1126\/science.1070532","volume":"296","author":"A Sawa","year":"2002","unstructured":"Sawa A, Snyder SH (2002) Schizophrenia: diverse approaches to a complex disease. Science 296:692\u2013695","journal-title":"Science"},{"issue":"1\u20132","key":"9473_CR160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00163-3","volume":"49","author":"ME Shenton","year":"2001","unstructured":"Shenton ME, Dickey CC, Frumin M, McCarley RW (2001) A review of MRI findings in schizophrenia. Schizophr Res 49(1\u20132):1\u201352","journal-title":"Schizophr Res"},{"key":"9473_CR161","doi-asserted-by":"crossref","first-page":"8244","DOI":"10.1074\/jbc.M109.054999","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara M, Ybanez MD, Win S, Than TA, Jain S, Gaarde WA, Han D, Kaplowitz N (2010) Silencing glycogen synthase kinase-3beta inhibits acetaminophen hepatotoxicity and attenuates JNK activation and loss of glutamate cysteine ligase and myeloid cell leukemia sequence 1. J Biol Chem 285:8244\u20138255","journal-title":"J Biol Chem"},{"key":"9473_CR200","doi-asserted-by":"crossref","unstructured":"Singh KK, De Rienzo G, Drane L, Mao Y, Flood Z, Madison J, Ferreira M, Bergen S, King C, Sklar P, Sive H, Tsai LH (2011) Common DISC1 polymorphisms disrupt Wnt\/GSK3B signaling and brain development. Neuron 72:545\u2013558","DOI":"10.1016\/j.neuron.2011.09.030"},{"key":"9473_CR201","doi-asserted-by":"crossref","unstructured":"Singh S, Goyal S, Modi S, Kumar P, Singh N, Bhatia T, Deshpanda SN, Khushu S (2014) Motor function deficits in Schizophrenia: an fMRI and VBM study. Neuroradiology. doi: 10.1007\/s00234-014-1325-3","DOI":"10.1007\/s00234-014-1325-3"},{"issue":"8","key":"9473_CR162","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neubiorev.2010.01.016","volume":"34","author":"R Smieskova","year":"2010","unstructured":"Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, Radue EW, McGuire PK, Riecher-R\u00f6ssler A, Borgwardt SJ (2010a) Neuroimaging predictors of transition to psychosis\u2013a systematic review and meta-analysis. Neurosci Biobehav Rev 34(8):1207\u20131222. doi: 10.1016\/j.neubiorev.2010.01.016","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"9473_CR163","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.neubiorev.2010.01.016","volume":"34","author":"R Smieskova","year":"2010","unstructured":"Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz R, Drewe J, Radue E, McGuire P, Riecher-R\u00f6ssler A, Borgwardt S (2010b) Neuroimaging predictors of transition to psychosis\u2014a systematic review and meta-analysis. Neurosci Biobehav Rev 34(8):1207\u20131222","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"9473_CR164","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1017\/S0033291711002716","volume":"42","author":"R Smieskova","year":"2012","unstructured":"Smieskova R, Fusar-Poli P, Aston J, Simon A, Bendfeldt K, Lenz C, Stieglitz RD, McGuire P, Riecher-Rossler A, Borgwardt SJ (2012a) Insular volume abnormalities associated with different transition probabilities to psychosis. Psychol Med 42(8):1613\u20131625. doi: 10.1017\/S0033291711002716","journal-title":"Psychol Med"},{"issue":"4","key":"9473_CR165","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/138161212799316046","volume":"18","author":"R Smieskova","year":"2012","unstructured":"Smieskova R, Fusar-Poli P, Riecher-Rossler A, Borgwardt S (2012b) Neuroimaging and resilience factors - staging of the at-risk mental state? Curr Pharm Des 18(4):416\u2013421","journal-title":"Curr Pharm Des"},{"issue":"10","key":"9473_CR166","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/hbm.21360","volume":"33","author":"R Smieskova","year":"2012","unstructured":"Smieskova R, Allen P, Simon A, Aston J, Bendfeldt K, Drewe J, Gruber K, Gschwandtner U, Klarhoefer M, Lenz C, Scheffler K, Stieglitz RD, Radue EW, McGuire P, Riecher-Rossler A, Borgwardt SJ (2012c) Different duration of at-risk mental state associated with neurofunctional abnormalities. A multimodal imaging study. Hum Brain Mapp 33(10):2281\u20132294. doi: 10.1002\/hbm.21360","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"9473_CR167","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.schres.2013.07.044","volume":"150","author":"X Song","year":"2013","unstructured":"Song X, Fan X, Song X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L (2013) Elevated levels of adiponectin and other cytokines in drug na\u00efve, first episode schizophrenia patients with normal weight. Schizophr Res 150(1):269\u2013273. doi: 10.1016\/j.schres.2013.07.044","journal-title":"Schizophr Res"},{"issue":"2","key":"9473_CR168","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/schbul\/sbs188","volume":"39","author":"NC Stefanis","year":"2013","unstructured":"Stefanis NC, Dragovic M, Power BD, Jablensky A, Castle D, Morgan VA (2013) Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend. Schizophr Bull 39(2):251\u2013254. doi: 10.1093\/schbul\/sbs188","journal-title":"Schizophr Bull"},{"key":"9473_CR169","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.biopsych.2009.05.006","volume":"66","author":"JM Stone","year":"2009","unstructured":"Stone JM, Day F, Tsagaraki H, Valli McLean MA et al (2009) Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to grey matter volume. Biol Psychiatry 66:533\u2013539","journal-title":"Biol Psychiatry"},{"key":"9473_CR170","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1001\/archpsyc.60.12.1187","volume":"60","author":"PF Sullivan","year":"2003","unstructured":"Sullivan PF, Kendler KS, Neale MC (2003) Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60:1187\u20131192","journal-title":"Arch Gen Psychiatry"},{"key":"9473_CR171","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","volume":"144","author":"A Suzuki","year":"2011","unstructured":"Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, Alberini CM (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell 144:810\u2013823","journal-title":"Cell"},{"issue":"Suppl","key":"9473_CR172","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1139\/y92-255","volume":"70","author":"RA Swanson","year":"1992","unstructured":"Swanson RA (1992) Physiologic coupling of glial glycogen metabolism to neuronal activity in brain. Can J Physiol Pharmacol 70(Suppl):S138\u2013S144","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"9473_CR173","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jpsychires.2013.07.029","volume":"47","author":"Y Takei","year":"2013","unstructured":"Takei Y, Suda M, Aoyama Y, Yamaguchi M, Sakurai N, Narita K, Fukuda M, Mikuni M (2013) Temporal lobe and inferior frontal gyrus dysfunction in patients with schizophrenia during face-to-face conversation: a near-infrared spectroscopy study. J Psychiatr Res 47(11):1581\u20131589. doi: 10.1016\/j.jpsychires.2013.07.029","journal-title":"J Psychiatr Res"},{"key":"9473_CR174","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.schres.2004.08.004","volume":"74","author":"YL Tan","year":"2005","unstructured":"Tan YL, Zhou DF, Zhang XY (2005) Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. Schizophr Res 74:263\u2013270","journal-title":"Schizophr Res"},{"key":"9473_CR175","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.schres.2008.11.014","volume":"108","author":"S Tayoshi","year":"2009","unstructured":"Tayoshi S, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S et al (2009) Metabolite changes and gender differences in schizophrenia using 3-Testa proton magnetic resonance spectroscopy (1H-MRS). Schizophr Res 108:69\u201377","journal-title":"Schizophr Res"},{"key":"9473_CR176","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1192\/bjp.bp.106.033670","volume":"191","author":"J Th\u00e9berge","year":"2007","unstructured":"Th\u00e9berge J, Williamson KE, Aoyama N, Drost DJ, Manchanda R, Malla AK, Northcott S, Menon RS, Neufeld RW, Rajakumar N, Pavlosky W, Densmore M, Schaefer B, Williamson PC (2007) Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia. Br J Psychiatry 191:325\u2013334","journal-title":"Br J Psychiatry"},{"key":"9473_CR177","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1176\/appi.ajp.161.6.1116","volume":"161","author":"P Tibbo","year":"2004","unstructured":"Tibbo P, Hanstock C, Valiakalayil A, Allen P (2004) 3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia. Am J Psychiatry 161:1116\u20131118","journal-title":"Am J Psychiatry"},{"key":"9473_CR178","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1086\/507566","volume":"79","author":"M Tosic","year":"2006","unstructured":"Tosic M, Ott J, Barral S, Bovet P, Deppen P et al (2006) Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79:586\u2013592","journal-title":"Am J Hum Genet"},{"key":"9473_CR179","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/mol.106.022715","volume":"70","author":"S Traver","year":"2006","unstructured":"Traver S, Marien M, Martin E, Hirsch EC, Michel PP (2006) The phenotypic differentiation of locus coeruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotrophin releasing factor through the activation of a cAMP-dependent signaling pathway. Mol Pharmacol 70:30\u201340","journal-title":"Mol Pharmacol"},{"key":"9473_CR180","doi-asserted-by":"crossref","first-page":"6804","DOI":"10.1523\/JNEUROSCI.20-18-06804.2000","volume":"20","author":"R Wender","year":"2000","unstructured":"Wender R, Brown AM, Fern R, Swanson RA, Farrell K et al (2000) Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 20:6804\u20136810","journal-title":"J Neurosci"},{"key":"9473_CR181","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuron.2011.10.023","volume":"72","author":"EM Wexler","year":"2011","unstructured":"Wexler EM, Geschwind DH (2011) DISC1: a schizophrenia gene with multiple personalities. Neuron 72:501\u2013503","journal-title":"Neuron"},{"key":"9473_CR182","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neulet.2011.07.020","volume":"502","author":"YQ Yang","year":"2011","unstructured":"Yang YQ, Sun S, Yu YQ, Li WJ, Zhang X, Xiu MH (2011) Decreased serum brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia. Neurosci Lett 502:37\u201340","journal-title":"Neurosci Lett"},{"key":"9473_CR183","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.pnpbp.2007.03.010","volume":"31","author":"R Yoshimura","year":"2007","unstructured":"Yoshimura R, Hori H, Sugita N, Ueda N, Kakihara S (2007) Treatment with risperidone for 4\u00a0weeks increased plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients. Prog Neuropsychopharmacol Biol Psychiatry 31:1072\u20131077","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9473_CR184","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/15622970802309617","volume":"11","author":"R Yoshimura","year":"2010","unstructured":"Yoshimura R, Ueda N, Hori H, Ikenouchi-Sugita A, Umene-Nakano W et al (2010) Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients. World J Biol Psychiatry 11:256\u2013261","journal-title":"World J Biol Psychiatry"},{"key":"9473_CR185","first-page":"103","volume":"5","author":"Q Yu","year":"2011","unstructured":"Yu Q, Plis SM, Erhardt EB, Allen EA, Sui J, Kiehl KA, Pearlson G, Calhoun VD (2011) Modular organization of functional network connectivity in healthy controls and patients with schizophrenia during the resting State. Front Syst Neurosci 5:103","journal-title":"Front Syst Neurosci"},{"key":"9473_CR186","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.euroneuro.2009.01.001","volume":"19","author":"CC Zai","year":"2009","unstructured":"Zai CC, Tiwari AK, De Luca V, Muller DJ, Bulgin N et al (2009) Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Eur Neuropsychopharmacol 19:317\u2013328","journal-title":"Eur Neuropsychopharmacol"},{"key":"9473_CR187","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jpsychires.2009.10.012","volume":"44","author":"XY Zhang","year":"2010","unstructured":"Zhang XY, Xiu MH, da Chen C, Zhu FY, Wu GY, Haile CN, Lu L, Kosten TA, Kosten TR (2010) Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements. J Psychiatr Res 44:429\u2013433","journal-title":"J Psychiatr Res"},{"issue":"2","key":"9473_CR188","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00213-012-2643-y","volume":"222","author":"XY Zhang","year":"2012","unstructured":"Zhang XY, Liang J, Chen DC, Xiu MH, De Yang F, Kosten TA, Kosten TR (2012) Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology 222(2):277\u2013284. doi: 10.1007\/s00213-012-2643-y","journal-title":"Psychopharmacology"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9473-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-014-9473-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9473-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T13:36:48Z","timestamp":1716730608000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-014-9473-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,8]]},"references-count":190,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["9473"],"URL":"https:\/\/doi.org\/10.1007\/s12640-014-9473-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,8]]}}}